Enhancing Community Delivery of Tissue Plasminogen Activator in Stroke Through Community-Academic Collaborative Clinical Knowledge Translation

Emergency Medicine Clinics of North America

Volumn 27, Issue 1, 2009, Pages 115-136

  Scott, Phillip A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Knowledge translation; Stroke; Thrombolytic; tPA; Treatment

Indexed keywords

ALTEPLASE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ALGORITHM; AWARENESS; BEHAVIOR CHANGE; BRAIN HEMORRHAGE; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMMUNITY CARE; DRUG APPROVAL; EMERGENCY MEDICINE; EPIDEMIOLOGICAL DATA; FIBRINOLYTIC THERAPY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ORGANIZATION; HUMAN; KNOWLEDGE; MEDICAL EDUCATION; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SELF CONCEPT; STATISTICAL SIGNIFICANCE; STROKE;

EID: 59849117815     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2008.07.001     Document Type: Review

References (107)

1. Morgenstern L.B., Staub L., Chan W., et al. Improving delivery of acute stroke therapy: the TLL temple foundation stroke project. Stroke 33 1 (2002) 160-166
2. Chiu D K.D., Villar-Cordova C., Kasner S.E., et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke 29 1 (1998) 18-22
3. Katzan I.L., Furlan A.J., Lloyd L.E., et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 283 9 (2000) 1151-1158
4. Chapman K.M., Woolfenden A.R., Graeb D., et al. Intravenous tissue plasminogen activator for acute ischemic stroke: a Canadian hospital's experience. Stroke 31 12 (2000) 2920-2924
5. Reed S.D., Cramer S.C., Blough D.K., et al. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 32 8 (2001) 1832-1840
6. Reeves M.J., Arora S., Broderick J.P., et al. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell national acute stroke registry. Stroke 36 6 (2005) 1232-1240
7. Schumacher H.C., Bateman B.T., Boden-Albala B., et al. Use of thrombolysis in acute ischemic stroke: analysis of the nationwide inpatient sample 1999 to 2004. Ann Emerg Med 50 2 (2007) 99-107
8. Kleindorfer D., Kissela B., Schneider A., et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke 35 2 (2004) e27-e29
9. Grotta J.C., Burgin W.S., El-Mitwalli A., et al. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol 58 12 (2001) 2009-2013
10. Morgenstern L.B., Bartholomew L.K., Grotta J.C., et al. Sustained benefit of a community and professional intervention to increase acute stroke therapy. Arch Intern Med 163 18 (2003) 2198-2202
11. Lyden P, Hickenbottom S. Professional education task force report. In: Improving the chain of recovery for acute stroke in your community; 2003. National Institute of Neurological Disorders and Stroke, Publication #NIH 03-5348.
12. Canadian Institute of Health Research. Knowledge translation strategy 2004-2009: innovation in action. Available at: http://www.cihr-irsc.gc.ca/e/26574.html. Accessed April 29, 2008.
13. Sung N.S., Crowley Jr. W.F., Genel M., et al. Central challenges facing the national clinical research enterprise. JAMA 289 10 (2003) 1278-1287
14. Lang E.S., Wyer P.C., and Haynes R.B. Knowledge translation: closing the evidence-to-practice gap. Ann Emerg Med 49 3 (2007) 355-363
15. Lang E.S., Wyer P.C., and Eskin B. Executive summary: knowledge translation in emergency medicine: establishing a research agenda and guide map for evidence uptake. Acad Emerg Med 14 11 (2007) 915-918
16. Joos S., and Hickam D. How health professionals influence health behavior: patient provider interaction and health care outcomes. In: Glanz K., Lewis F., and Rimer B. (Eds). Health behavior and health education: theory, research and practice (1990), Jossey Bass, San Francisco (CA) 216-241
17. Hickenbottom S., and Morgenstern L. Educating North America: lessons learned. Seminars in Cerebrovascular Disease and Stroke 1 2 (2001) 167-175
18. Sutton S. Social-psychological approaches to understanding addictive behaviours: attitude-behaviour and decision-making models. Br J Addict 82 4 (1987) 355-370
19. Weinstein N. Testing four competing theories of health-protective behavior. Health Psychol 12 4 (1993) 324-333
20. Anonymous. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA stroke study group. [see comments]. N Engl J Med 333 24 (1995) 1581-1587
21. Kwiatkowski T.G., Libman R.B., Frankel M., et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator stroke study group. [see comments]. N Engl J Med 340 23 (1999) 1781-1787
22. Anonymous. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre acute stroke trial-Italy (MAST-I) group. [comment] [see comments]. Lancet 346 8989 (1995) 1509-1514
23. Anonymous. Thrombolytic therapy with streptokinase in acute ischemic stroke. The multicenter acute stroke trial-Europe study group. [see comments]. N Engl J Med 335 3 (1996) 145-150
24. Clark W.M., Wissman S., Albers G.W., et al. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. [see comments]. JAMA 282 21 (1999) 2019-2026
25. Donnan G.A., Davis S.M., Chambers B.R., et al. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian streptokinase (ASK) trial study group. JAMA 276 12 (1996) 961-966
26. Hacke W., Kaste M., Fieschi C., et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European cooperative acute stroke study (ECASS). [see comments]. JAMA 274 13 (1995) 1017-1025
27. Hacke W., Kaste M., Fieschi C., et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian acute stroke study investigators. [see comments]. Lancet 352 9136 (1998) 1245-1251
28. Wahlgren N., Ahmed N., Davalos A., et al. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. Lancet 369 9558 (2007) 275-282
29. Anonymous. Practice advisory: thrombolytic therapy for acute ischemic stroke-summary statement. Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 47 3 (1996) 835-839
30. Adams Jr. H.P., del Zoppo G., Alberts M.J., et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38 5 (2007) 1655-1711
31. Anonymous. Proceedings of a National Symposium on rapid identification and treatment of acute stroke. In: John R., Marler P.W.J., and Marian E. (Eds). Rapid identification and treatment of acute stroke; 1997 (1997), National Institute of Neurological Disorders and Stroke, Bethesda (MD)
32. Improving the chain of recovery for acute stroke in your community; 2003. National Institute of Neurological Disorders and Stroke, Publication #NIH 03-5348.
33. ACEP agrees with reservations to new stroke guidelines. ACEP News. October 1996;3.
34. ACEP Policy Statement: Use of intravenous tPA for the management of acute stroke in the emergency department. American College of Emergency Physicians, 2002. Available at:. http://www.acep.org/practres.aspx?id=29834 Accessed November, 2002
35. AAEM Work Group on Thrombolytic Therapy in Stroke. Position statement of the American Academy of Emergency Medicine on the use of intravenous thrombolytic therapy in the treatment of stroke. Available at: http://www.aaem.org/positionstatements/thrombolytictherapy.php. Accessed on June 2008.
36. Ingall T.J., O'Fallon W.M., Asplund K., et al. Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Stroke 35 10 (2004) 2418-2424
37. Albers G.W., Bates V.E., Clark W.M., et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the standard treatment with alteplase to reverse stroke (STARS) study. [see comments]. JAMA 283 9 (2000) 1145-1150
38. Hill M.D., and Buchan A.M. Thrombolysis for acute ischemic stroke: results of the Canadian alteplase for stroke effectiveness study. CMAJ 172 10 (2005) 1307-1312
39. Kwan J., Hand P., and Sandercock P. A systematic review of barriers to delivery of thrombolysis for acute stroke. Age Ageing 33 2 (2004) 116-121
40. Rogers W., Bowlby L., Chandra N., et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation 90 4 (1994) 2103-2114
41. Kunnel B., and Heller M. Thrombolytics and stroke: what do emergency medicine residents perceive?. Acad Emerg Med 6 11 (1999) 1174-1176
42. Brown D.L., Barsan W.G., Lisabeth L.D., et al. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke. Ann Emerg Med 46 1 (2005) 56-60
43. Cabana M.D., Rand C.S., Powe N.R., et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 282 15 (1999) 1458-1465
44. Cabana M.D., Ebel B.E., Cooper-Patrick L., et al. Barriers pediatricians face when using asthma practice guidelines. Arch Pediatr Adolesc Med 154 7 (2000) 685-693
45. Meurer W.J., Frederiksen S.M., Majersik J.J., et al. Qualitative data collection and analysis methods: the INSTINCT trial. Acad Emerg Med 14 11 (2007) 1064-1071
46. Greco P.J., and Eisenberg J.M. Changing physicians' practices. N Engl J Med 329 17 (1993) 1271-1273
47. Browner W., Baron R., Solkowitz S., et al. Physician management of hypercholesterolemia. A randomized trial of continuing medical education. West J Med 161 6 (1994) 572-578
48. Boissel J., Collet J., Alborini A., et al. Education program for general practitioners on breast and cervical cancer screening: a randomized trial. PRE.SA.GF collaborative group. Rev Epidemiol Sante Publique 43 6 (1995) 541-547
49. Davis D., O'Brien M.A.T., Freemantle N., et al. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?. JAMA 282 9 (1999) 867-874
50. Kottke T.E., Brekke M.L., Solberg L.I., et al. A randomized trial to increase smoking intervention by physicians. Doctors helping smokers, round I. JAMA 261 14 (1989) 2101-2106
51. Levinson W., and Roter D. The effects of two continuing medical education programs on communication skills of practicing primary care physicians. J Gen Intern Med 8 6 (1993) 318-324
52. Maiman L.A., Becker M.H., Liptak G.S., et al. Improving pediatricians' compliance-enhancing practices. A randomized trial. Am J Dis Child 142 7 (1988) 773-779
53. Ockene I.S., Hebert J.R., Ockene J.K., et al. Effect of training and a structured office practice on physician-delivered nutrition counseling: the Worcester-area trial for counseling in hyperlipidemia (WATCH). Am J Prev Med 12 4 (1996) 252-258
54. Roter D.L., Hall J.A., Kern D.E., et al. Improving physicians' interviewing skills and reducing patients' emotional distress. A randomized clinical trial. Arch Intern Med 155 17 (1995) 1877-1884
55. White C.W., Albanese M.A., Brown D.D., et al. The effectiveness of continuing medical education in changing the behavior of physicians caring for patients with acute myocardial infarction. A controlled randomized trial. Ann Intern Med 102 5 (1985) 686-692
56. IV t-PA Interventional therapy for acute stroke patients: a debate. Canadian Association of Emergency Physicians Annual Scientific Meeting. Calgary, Alberta, Canada, 2002.
57. Hoffman J.R. Predicted impact of intravenous thrombolysis. Another trial is needed. BMJ 320 7240 (2000) 1007
58. Hoffman J.R. Alteplase for stroke. Why were these authors of the commentaries chosen?. BMJ 324 7353 (2002) 1581 [author reply]
59. Smith R.W., Scott P.A., Grant R.J., et al. Emergency physician treatment of acute stroke with recombinant tissue plasminogen activator: a retrospective analysis. Academic Emergency Medicine 6 6 (1999) 618-625
60. Scott P., Davis L., Frederiksen S., et al. Emergency physician administration of rt-PA in acute stroke: five-year analysis of treatment and outcome. [abstract]. Acad Emerg Med 9 5 (2002) 447
61. Scott P., Smith R., Davis L., et al. Time analysis of emergency physician delivery of rt-PA in acute ischemic stroke. [abstract A327]. Acad Emerg Med 7 5 (2000) 535
62. Scott P.A., Smith R.W., Chudnofsky C.R., et al. Emergency physician administration of rt-PA in acute stroke: analysis of treatment and outcome. [abstract]. Stroke 30 1 (1999) 244
63. Scott P., and Silbergleit R. Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes. Ann Emerg Med 42 5 (2003) 611-618
64. Scott P., Silbergleit R., Frederiksen S., et al. Long term mortality in stroke patients treated with TPA: emergency physicians vs NINDS. [abstract]. Acad Emerg Med 10 5 (2003) 433
65. Bandura A. Social foundations of thought and action: a social cognitive theory (1986), Prentice-Hall, Inc., Engelwood Cliffs (NJ)
66. Hayward R.S. Clinical practice guidelines on trial. CMAJ 156 12 (1997) 1725-1727
67. Lomas J., Anderson G.M., Domnick-Pierre K., et al. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 321 19 (1989) 1306-1311
68. Woolf S.H. Practice guidelines: a new reality in medicine. III. Impact on patient care. Arch Intern Med 153 23 (1993) 2646-2655
69. Gass D.A., and Curry L. Physicians' and nurses' retention of knowledge and skill after training in cardiopulmonary resuscitation. Can Med Assoc J 128 5 (1983) 550-551
70. Lum M.E., and Galletly D.C. Resuscitation skills of first year postgraduate doctors. N Z Med J 102 873 (1989) 406-408
71. Cappelle C., and Paul R.I. Educating residents: the effects of a mock code program. Resuscitation 31 2 (1996) 107-111
72. Funkhouser M.J., and Hayward M.F. Multidisciplinary mock codes: dream it, plan it, do it, rate it. J Nurses Staff Dev 5 5 (1989) 231-237
73. Main D.S., Cohen S.J., and DiClemente C.C. Measuring physician readiness to change cancer screening: preliminary results. Am J Prev Med 11 1 (1995) 54-58
74. Frey J.L., Jahnke H.K., Goslar P.W., et al. tPA by telephone: extending the benefits of a comprehensive stroke center. Neurology 64 1 (2005) 154-156
75. Vaishnav A.G., Pettigrew L.C., and Ryan S. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals. Clin Neurol Neurosurg (2008)
76. Schwab S., Vatankhah B., Kukla C., et al. Long-term outcome after thrombolysis in telemedical stroke care. Neurology 69 9 (2007) 898-903
77. Schwamm L.H., Rosenthal E.S., Hirshberg A., et al. Virtual teleStroke support for the emergency department evaluation of acute stroke. Acad Emerg Med 11 11 (2004) 1193-1197
78. Berlo D. The process of communication: an introduction to theory and practice (1960), Holt, Rinehart & Winston, New York
79. Davis D.A., Thomson M.A., Oxman A.D., et al. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 274 9 (1995) 700-705
80. Davis D.A., and Taylor-Vaisey A. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ 157 4 (1997) 408-416
81. Mazmanian P.E., and Davis D.A. Continuing medical education and the physician as a learner: guide to the evidence. JAMA 288 9 (2002) 1057-1060
82. Pimlott N.J., Hux J.E., Wilson L.M., et al. Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial. CMAJ 168 7 (2003) 835-839
83. Parrino T.A. The nonvalue of retrospective peer comparison feedback in containing hospital antibiotic costs. Am J Med 86 4 (1989) 442-448
84. Hershey C.O., Goldberg H.I., and Cohen D.I. The effect of computerized feedback coupled with a newsletter upon outpatient prescribing charges. A randomized controlled trial. Med Care 26 1 (1988) 88-94
85. McPhee S.J., Bird J.A., Jenkins C.N., et al. Promoting cancer screening. A randomized, controlled trial of three interventions. Arch Intern Med 149 8 (1989) 1866-1872
86. Tierney W.M., Hui S.L., and McDonald C.J. Delayed feedback of physician performance versus immediate reminders to perform preventive care. Effects on physician compliance. Med Care 24 8 (1986) 659-666
87. Salemi C., Canola M.T., and Eck E.K. Hand washing and physicians: how to get them together. Infect Control Hosp Epidemiol 23 1 (2002) 32-35
88. Oster N.S., and Doyle C.J. Critical incident stress and challenges for the emergency workplace. Emerg Med Clin North Am 18 2 (2000) 339-353 x-xi
89. Greer A.L. The state of the art versus the state of the science. The diffusion of new medical technologies into practice. Int J Technol Assess Health Care 4 1 (1988) 5-26
90. Mittman B.S., Tonesk X., and Jacobson P.D. Implementing clinical practice guidelines: social influence strategies and practitioner behavior change. QRB Qual Rev Bull 18 12 (1992) 413-422
91. Soumerai S.B., McLaughlin T.J., Gurwitz J.H., et al. Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. JAMA 279 17 (1998) 1358-1363
92. Lomas J., Enkin M., Anderson G.M., et al. Opinion leaders vs audit and feedback to implement practice guidelines. Delivery after previous cesarean section. JAMA 265 17 (1991) 2202-2207
93. Everitt D.E., Soumerai S.B., Avorn J., et al. Changing surgical antimicrobial prophylaxis practices through education targeted at senior department leaders. Infect Control Hosp Epidemiol 11 11 (1990) 578-583
94. Soumerai S.B., Salem-Schatz S., Avorn J., et al. A controlled trial of educational outreach to improve blood transfusion practice. JAMA 270 8 (1993) 961-966
95. Avorn J., and Soumerai S.B. A new approach to reducing suboptimal drug use. JAMA 250 13 (1983) 1752-1753
96. Ray W.A., Schaffner W., and Federspiel C.F. Persistence of improvement in antibiotic prescribing in office practice. JAMA 253 12 (1985) 1774-1776
97. Ray W.A., Blazer II D.G., Schaffner W., et al. Reducing long-term diazepam prescribing in office practice. A controlled trial of educational visits. JAMA 256 18 (1986) 2536-2539
98. Coleman R.W., Rodondi L.C., Kaubisch S., et al. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J Med 90 4 (1991) 439-444
99. Soumerai S.B., Ross-Degnan D., Avorn J., et al. Effects of medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 325 15 (1991) 1072-1077
100. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355 26 (2006) 2725-2732
101. Davenport J., Hanson S.K., Altafullah I.M., et al. tPA: a rural network experience. Stroke 31 6 (2000) 1457-1458
102. Grond M., Stenzel C., Schmulling S., et al. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 29 8 (1998) 1544-1549
103. Katzan I.L., Sila C.A., and Furlan A.J. Community use of intravenous tissue plasminogen activator for acute stroke: results of the brain matters stroke management survey. Stroke 32 4 (2001) 861-865
104. Wang D.Z., Rose J.A., Honings D.S., et al. Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. Stroke 31 1 (2000) 77-81
105. Tanne D., Bates V.E., Verro P., et al. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA stroke survey group. Neurology 53 2 (1999) 424-427
106. Alberts M.J. tPA in acute ischemic stroke: United States experience and issues for the future. Neurology 51 3 Suppl 3 (1998) S53-S55
107. Broderick J., Brott T., Kothari R., et al. The Greater Cincinnati/Northern Kentucky stroke study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke 29 2 (1998) 415-421